Monique has been in pharmaceutical industry since 1977 and worked in both clinical research as well as regulatory affairs in positions of increasing responsibility to executive functions in several companies, among them Schering A.G., Beecham Pharma, Cyanamid International, Hoechst, Bristol-Myers Squibb, Schering Plough, and Janssen. Throughout her career she worked on a number of different developmental and marketed drugs, among others cytostatic drugs, hematological oncology products, hormone therapy in oncology and infertility and contraception, antivirals in HIV and hepatitis, antibiotics, cytokines, anxiolytics, antidepressants, antipsychotics, anti-Parkinson drugs, cardiovascular and vaso-active drugs, gastro-intestinal drugs, topical corticosteroids, antihistamines, etc.
Monique founded Pharmakon SA in 2002.As a consultant Monique has been supporting the development and the subsequent filing of several new products through the different registration systems in Europe. She has acted as the key contact person with EMA on several occasions.
She has also been managing temporarily the operations of the EORTC, a pan-European academic research organization in cancer.
Monique is acting as a consultant to Trade Associations and Health Authorities on the implementation of the EU Clinical Trial Directive and specific clinical research topics. She is a regular lecturer at the university of Brussels and on several international platforms and the co-author of the reference manual “Clinical Trials in Belgium”.